Keratin‐positive giant cell‐rich tumors of soft tissue with HMGA2::NCOR2 fusions
Journal of Cutaneous Pathology · 2023
DOI: 10.1111/cup.14497 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, 2023. Verfasst von Maximillian A Weigelt und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Giant Cell Tumors, Soft Tissue Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Giant cell tumor of soft tissue (GCT‐ST) is a rare soft tissue neoplasm that is morphologically similar to but genetically distinct from giant cell tumor of bone. A novel keratin‐positive GCT‐ST (KPGCT‐ST) harboring HMGA2::NCOR2 fusions was recently discovered. Fewer than 30 cases have been described; herein is reported an additional seven.
Methods
Cases diagnosed as GCT‐ST were retrieved from institutional archives and consultation files. The histopathologic characteristics were assessed, and the electronic medical record was reviewed.
Results
Seven tumors were identified in six women and one man with a median age of 23 years. All patients underwent excision; no recurrences or metastases were noted during a median follow‐up period of 7 months. Histopathologically, the tumors were characterized by a multinodular proliferation of keratin‐positive mononuclear cells with evenly admixed osteoclast‐like giant cells and absent neoplastic bone. A fibrous capsule with lymphoid cuffing was frequently seen. Foamy macrophages, inflammation, hemorrhage, and hemosiderin were variably present. The HMGA2::NCOR2 fusion was detected in all cases.
Conclusions
Our findings support previously reported hypotheses that KPGCT‐ST is a spectrum of the same entity as the recently described xanthogranulomatous epithelial tumor. Although follow‐up data are limited, to date, KPGCT‐ST appears to follow an indolent course.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Robert J. Tomsich Pathology and Laboratory Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
- Department of Pathology, Summit Pathology, Loveland, Colorado, USA.
ORCID-Profile: Maximillian A Weigelt, Steven D Billings, Jennifer S Ko
Zitieren
APA
Weigelt, M. A., Azzato, E. M., Habermehl, G. K., Billings, S. D., Ko, J. S., & Fritchie, K. J. (2023). Keratin‐positive giant cell‐rich tumors of soft tissue with HMGA2::NCOR2 fusions. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14497
Vancouver
Weigelt MA, Azzato EM, Habermehl GK, Billings SD, Ko JS, Fritchie KJ. Keratin‐positive giant cell‐rich tumors of soft tissue with HMGA2::NCOR2 fusions. Journal of Cutaneous Pathology. 2023. doi:10.1111/cup.14497
BibTeX
@article{Weigelt2023,
author = {Weigelt, Maximillian A and Azzato, Elizabeth M and Habermehl, Gabriel K and Billings, Steven D and Ko, Jennifer S and Fritchie, Karen J},
title = {Keratin‐positive giant cell‐rich tumors of soft tissue with HMGA2::NCOR2 fusions},
journal = {Journal of Cutaneous Pathology},
year = {2023},
doi = {10.1111/cup.14497}
}
EUVIMED